1-20 of 38
Michelle Fanale
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Systematic Literature Review of Clinical Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated in the Third-Line or Later Setting

Sarah Bandy, Amy Wu, Daniel Gratie, Ruslan Horblyuk, Karen Repetny, Michelle Fanale, Betsy Mitchell, Nicholas Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6443.
https://doi.org/10.1182/blood-2024-203238
Published: 2024
Journal Articles

Durability of Complete Responses in Patients from the ECHELON-3 Study

Christopher Yasenchak, Nancy L. Bartlett, Jeong-A Kim, Uwe Hahn, Craig A. Portell, Francesco Zaja, Thorsten Zenz, Cecily Forsyth, Jin Seok Kim, Seok-Goo Cho, Jae-Yong Kwak, Hao-Yuan Wang, Herve Ghesquieres, Grzegorz S. Nowakowski, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Frank Stenner
Journal: Blood
Blood (2024) 144 (Supplement 1): 3101.
https://doi.org/10.1182/blood-2024-194158
Published: 2024
Journal Articles

Outcomes By Refractory Status and Prior Therapies Received in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study

Uwe Hahn, Nancy L. Bartlett, Jeong-A Kim, Krimo Bouabdallah, Nicholas Forward, Tsai-Yun Chen, Vincent Camus, Ming-Chung Wang, Philippe Carassou, Enrico Derenzini, Hung Chang, Fritz Offner, Herve Ghesquieres, Grzegorz S. Nowakowski, Christopher Yasenchak, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Craig A. Portell
Journal: Blood
Blood (2024) 144 (Supplement 1): 4489.
https://doi.org/10.1182/blood-2024-200914
Published: 2024
Journal Articles

Outcomes in Older Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study

Nancy L. Bartlett, Jeong-A Kim, Uwe Hahn, Isabelle Fleury, Kamel Laribi, Juan Miguel Bergua Burgues, Craig A. Portell, Melina Boutin, Blanca Sanchez Gonzalez, Selay Lam, Sung Yong Oh, Judit Mészáros Joergensen, Young Rok Do, Herve Ghesquieres, Grzegorz S. Nowakowski, Christopher Yasenchak, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Vincent Ribrag
Journal: Blood
Blood (2024) 144 (Supplement 1): 4483.
https://doi.org/10.1182/blood-2024-200836
Published: 2024
Journal Articles

Real-World Treatment Patterns & Characteristics of Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Retrospective Analysis of US Claims (2017-2024)

John M. Burke, Ziqi Zhou, Cynthia Gutierrez, Anran Shao, Marley Boyd, Sina Noshad, Andriana Hohlbauch, Nicholas Liu, Karen Repetny, Michelle Fanale, Betsy Mitchell, Tycel Phillips
Journal: Blood
Blood (2024) 144 (Supplement 1): 7810.
https://doi.org/10.1182/blood-2024-203554
Published: 2024
Journal Articles

A Retrospective Analysis of US Commercial and Medicare Closed-Claims Databases to Evaluate Real-World Characteristics and Treatment Patterns of Patients with Diffuse Large B-Cell Lymphoma (2017-2023)

Tycel Phillips, Ziqi Zhou, Cynthia Gutierrez, Anran Shao, Marley Boyd, Sina Noshad, Andriana Hohlbauch, Nicholas Liu, Karen Repetny, Michelle Fanale, Betsy Mitchell, John M. Burke
Journal: Blood
Blood (2024) 144 (Supplement 1): 7809.
https://doi.org/10.1182/blood-2024-203380
Published: 2024
Journal Articles

Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation

Clinical Trials & Observations
Mani Akhtari, Sarah A. Milgrom, Chelsea C. Pinnix, Jay P. Reddy, Wenli Dong, Grace L. Smith, Osama Mawlawi, Zeinab Abou Yehia, Jillian Gunther, Eleanor M. Osborne, Therese Y. Andraos, Christine F. Wogan, Eric Rohren, Naveen Garg, Hubert Chuang, Joseph D. Khoury, Yasuhiro Oki, Michelle Fanale, Bouthaina S. Dabaja
Journal: Blood
Blood (2018) 131 (1): 84–94.
https://doi.org/10.1182/blood-2017-04-773838
Published: 2018
Journal Articles

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma

Clinical Trials & Observations
Barbara Pro, Ranjana Advani, Pauline Brice, Nancy L. Bartlett, Joseph D. Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle Fanale, Joseph M. Connors, Keenan Fenton, Dirk Huebner, Juan M. Pinelli, Dana A. Kennedy, Andrei Shustov
Journal: Blood
Blood (2017) 130 (25): 2709–2717.
https://doi.org/10.1182/blood-2017-05-780049
Published: 2017
Includes: Supplemental data
Journal Articles

Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma

Clinical Trials & Observations
Joseph M. Connors, Stephen M. Ansell, Michelle Fanale, Steven I. Park, Anas Younes
Journal: Blood
Blood (2017) 130 (11): 1375–1377.
https://doi.org/10.1182/blood-2017-05-784678
Published: 2017
Journal Articles

New insights into NLPHL transformation

Clinical Trials & Observations
Michelle Fanale
Journal: Blood
Blood (2016) 127 (16): 1946–1947.
https://doi.org/10.1182/blood-2016-03-699108
Published: 2016
Journal Articles

SUV max on Pre-Treatment FDG PET Scan Is Not Predictive of Outcome in Follicular Lymphoma after R-CHOP Threapy

Mohamed Amin Ahmed, MD, Nathan Fowler, MD, Long Ma, Mansoor Noorani, Karishma Phansalkar, Fredrick B. Hagemeister, MD, Jorge E. Romaguera, MD, Luis Fayad, MD, Alma Rodriguez, MD, Felipe Samaniego, MD, Michelle Fanale, Michael Wang, MD, Yasuhiro Oki, MD, Francesco Turturro, MD, Jason R. Westin, MD, Larry W. Kwak, MD PhD, Loretta J. Nastoupil, MD, Chan Cheah, Lei Feng, MS, Eric M Rohren, MD PhD, Richard E. Davis, MD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2014) 124 (21): 1629.
https://doi.org/10.1182/blood.V124.21.1629.1629
Published: 2014
Journal Articles

Sequence Level Analysis of Hodgkin Lymphoma Clonotypes Detected in Peripheral Blood Using a Next-Generation Sequencing Approach

Yasuhiro Oki, MD, Sattva S. Neelapu, Michelle Fanale, Larry W. Kwak, MD PhD, Luis Fayad, MD, Maria Alma Rodriguez, Michael Wallace, Mark Klinger, Victoria Carlton, Katherine A Kong, Malek Faham, Anas Younes
Journal: Blood
Blood (2014) 124 (21): 1610.
https://doi.org/10.1182/blood.V124.21.1610.1610
Published: 2014
Journal Articles

Preliminary Report of a Multicenter Prospective Phase II Study of DA-EPOCH-R in MYC-Rearranged Aggressive B-Cell Lymphoma

Kieron Dunleavy, MD, Michelle Fanale, MD, Ann LaCasce, MD, Ariela Noy, Paolo Caimi, MD, Samir Parekh, MD, John W Hayslip, MD, Deepa Jagadeesh, MD MPH, Raymond S Lord, Mary J Lechowicz, MD, Rakesh Gaur, MD, Andrea Lucas, RN, Louis M Staudt, MD PhD, Seth M. Steinberg, PhD, Brad Kahl, MD, Jonathan W. Friedberg, MD, Richard F Little, MPH, MD, Nancy L Bartlett, MD, Wyndham H Wilson, MD PhD
Journal: Blood
Blood (2014) 124 (21): 395.
https://doi.org/10.1182/blood.V124.21.395.395
Published: 2014
Journal Articles

A novel prognostic scoring system for NLPHL

Michelle Fanale
Journal: Blood
Blood (2013) 122 (26): 4154–4155.
https://doi.org/10.1182/blood-2013-11-533109
Published: 2013
Journal Articles

Significant Activity Of The mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat In Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Filip Janku, MD, PhD, Ignacio Garrido-Laguna, MD, Vivianne Velez-Bravo, Gerald S. Falchook, MD, Vivek Subbiah, MD, David S. Hong, MD, Yasuhiro Oki, MD, Jason R. Westin, MD, Cesar A. Nunez, M.D., Luis E Fayad, Larry W. Kwak, MD, PhD, Elizabeth J Shpall, MD, Jennifer J. Wheler, MD, Winnie Liang, PhD, Bodour Salhia, PhD, Funda Meric-Bernstam, MD, Razelle Kurzrock, Michelle Fanale, MD
Journal: Blood
Blood (2013) 122 (21): 3048.
https://doi.org/10.1182/blood.V122.21.3048.3048
Published: 2013
Journal Articles

R-HCVAD Alternating with R-Methotrexate Cytarabine in Younger Patients (pts) with IH and High-Risk Age Adjusted-IPI DLBCL

Yasuhiro Oki, MD, Jason R. Westin, MD, Nathan Fowler, MD, Sattva Neelapu, MD, F.B. Hagemeister, MD, Peter McLaughlin, MD, Larry W. Kwak, MD, PhD, Jorge Enrique Romaguera, Michelle Fanale, MD, Anas Younes, MD, Maria A. Rodriguez, MD, Robert Z. Orlowski, MD, PhD, Michael Wang, M.D., Souzanne T Ouzounian, Felipe Samaniego, M.D., Luis Fayad, MD
Journal: Blood
Blood (2012) 120 (21): 3707.
https://doi.org/10.1182/blood.V120.21.3707.3707
Published: 2012
Journal Articles

Phase II Safety and Efficacy Study of CT-011, a Humanized Anti-PD-1 Monoclonal Antibody, in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma

Jason R. Westin, MD, Fuliang Chu, PhD, Luis E Fayad, MD, Larry W Kwak, MD, PhD, Nathan H Fowler, MD, Jorge E Romaguera, MD, F.B. Hagemeister, MD, Michelle Fanale, MD, Felipe Samaniego, M.D., Rochelle Allen, RN, Lei Feng, Ph.D, Veerabhadran Baladandayuthapani, PhD, Rinat Rotem-Yehudar, PhD, Sattva Neelapu, MD
Journal: Blood
Blood (2012) 120 (21): 793.
https://doi.org/10.1182/blood.V120.21.793.793
Published: 2012
Journal Articles

TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas

Jinsheng Weng, Seema Rawal, Fuliang Chu, Hyun Jun Park, Rakesh Sharma, David A. Delgado, Luis Fayad, Michelle Fanale, Jorge Romaguera, Amber Luong, Larry W. Kwak, Sattva S. Neelapu
Journal: Blood
Blood (2012) 120 (8): 1613–1623.
https://doi.org/10.1182/blood-2011-09-382838
Published: 2012
Includes: Supplemental data
Journal Articles

Experience with obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma

Yasuhiro Oki, Amanda Copeland, Fredrick Hagemeister, Luis E. Fayad, Michelle Fanale, Jorge Romaguera, Anas Younes
Journal: Blood
Blood (2012) 119 (9): 2171–2172.
https://doi.org/10.1182/blood-2011-11-391037
Published: 2012
Journal Articles

Anti-CD74 Antibody hLL1 Is Associated with Lymphoma and Chronic Lymphocytic Leukemia Cell Effects In Vivo

Felipe Samaniego, MD, Jillian F Wise, BS, Luis Fayad, MD, Michelle Fanale, MD, Fredrick Hagemeister, MD, Vijairam Selvaraj, MD, David M. Goldenberg, ScD, MD, Larry W. Kwak, MD, PhD, Zuzana Berkova, PhD
Journal: Blood
Blood (2011) 118 (21): 1796.
https://doi.org/10.1182/blood.V118.21.1796.1796
Published: 2011